FerroptoCure Inc.

  • Biotech or pharma, animal health
  • Academic, tech transfer
  • Biotech or pharma, therapeutic R&D

FerroptoCure is a clinical stage company developing novel new ferroptosis inducing anti-cancer therapy. FerroptoCure has completed a Phase1a trial of the lead project in Japan and seeking partners to out-license and investors.

Address

Tokyo
Japan

Website

https://ferroptocure.com/en

Contact Exhibitor


Loading
View all Partnering Companies

BIO DOUBLE HELIX SPONSORS

Our sponsors help support BIO's mission to support and advocate for the biotechnology industry.

BIO HELIX SPONSORS